Srihari Gopal, MD, MHS

Vice President Global Program Lead Neuroscience, Bristol Myers Squibb

Biopharma and Medical Device Industry Council

Experienced Phase 1-4 drug developer across multiple disease areas: Heart Failure, Hypertension, Pulmonary Arterial Hypertension, Rare Disease, Alzheimer’s, Depression, Schizophrenia, Neuropathic Pain. Developed multiple small molecules, monoclonal antibodies and siRNA. Cross functional team lead for multiple assets in development, the largest with annual worldwide sales of $4B USD per year.

During my professional career, I have participated and/or led 15 NDA, 9 MAA, 2 JNDA and 12 IND approvals. Broad experience negotiating and presenting before regulatory agencies including FDA, EMA, PMDA, Health Canada, etc. Published author on 250+ publications, posters, book chapters and 30+ patents.